DJIA 17,569.12 212.25 1.22%
NASDAQ 4,708.96 64.65 1.39%
S&P 500 2,038.60 25.71 1.28%
market minute promo

6.35 -0.03 (-0.47%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

OREX $6.33 -0.78%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.48
Previous Close $6.38
Daily Range $6.30 - $6.52
52-Week Range $3.11 - $7.82
Market Cap $782.1M
P/E Ratio -11.81
Dividend (Yield) $0.00 (0.0%)
Volume 1,606,579
Average Daily Volume 3,777,198
Current FY EPS -$0.42





Orexigen Therapeutics, Inc. (OREX) Description

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity. Website:

News & Commentary

This Growing Concern Accounts For Nearly 500,000 Cancer Cases Each Year

A recent World Health Organization study shows that this growing problem is responsible for nearly a half-million cancer diagnoses each year.

4 Top Ranked Biotech Stocks that Beat the Market in 2014 - Analyst Blog

Low-Cost Contrave Fuels Anti-Obesity Drugs Recovery From Thanksgiving

Why Should Investors Expect Physicians To Treat Obesity With Pharmacotherapy?

Contrave Sales Continue To Impress

Arena: Belviq Sales See Pleasant Rebound

Assessing The Beginnings Of The Orexigen Launch Of Contrave

Contrave Sales Are Driven By Reps And Discounts, Not Insurance (Yet)

How To Profit From The Obesity Epidemic

These 4 Biotech Stocks Have Been On Fire

See More OREX News...

OREX's Top Competitors

OREX $6.35 (-0.47%)
Current stock: OREX
AMGN $166.11 (1.61%)
Current stock: AMGN
GILD $104.75 (2.29%)
Current stock: GILD
BIIB $344.21 (3.40%)
Current stock: BIIB